Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Chronic Renal Failure

Free Subscription Articles published in Nephron Retrieve available abstracts of 113 articles: HTML format Text format

Single Articles

July 2018
1. COZZOLINO M, Bolasco P, Ronco C, Conte G, et al
   Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study.
   Nephron. 2018 Jul 17:1-9. doi: 10.1159/000490769.
   PubMed     Text format     Abstract available
   
   
   
2. OTSUKI T, Utsunomiya K, Moriuchi M, Horikoshi S, et al
   Effect of Sucroferric Oxyhydroxide on Fibroblast Growth Factor 23 Levels in Hemodialysis Patients.
   Nephron. 2018 Jul 10:1-8. doi: 10.1159/000490903.
   PubMed     Text format     Abstract available
   
   
   
3. TANDUKAR S, Fried LF
   Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
   Nephron. 2018 Jul 4:1-5. doi: 10.1159/000490008.
   PubMed     Text format     Abstract available
   
   
   June 2018
4. GRITTER M, Vogt L, Yeung SMH, Wouda RD, et al
   Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease.
   Nephron. 2018 Jun 29:1-10. doi: 10.1159/000490261.
   PubMed     Text format     Abstract available
   
   
   
5. FULLER DS, Robinson BM, Locatelli F, Pisoni RL, et al
   Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study.
   Nephron. 2018 Jun 26:1-7. doi: 10.1159/000490202.
   PubMed     Text format     Abstract available
   
   
   
6. FUJISAKI K, Tanaka S, Taniguchi M, Matsukuma Y, et al
   Study on Dialysis Session Length and Mortality in Maintenance Hemodialysis Patients: The Q-Cohort Study.
   Nephron. 2018 Jun 7:1-8. doi: 10.1159/000489680.
   PubMed     Text format     Abstract available
   
   
   
7. KUCZERA P, Adamczak M, Machnik G, Okopien B, et al
   Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism.
   Nephron. 2018 Jun 7:1-7. doi: 10.1159/000489278.
   PubMed     Text format     Abstract available
   
   
   
8. STRINGUETTA BELIK F, Oliveira E Silva VR, Braga GP, Bazan R, et al
   Influence of Intradialytic Aerobic Training in Cerebral Blood Flow and Cognitive Function in Patients with Chronic Kidney Disease: A Pilot Randomized Controlled Trial.
   Nephron. 2018 Jun 7:1-9. doi: 10.1159/000490005.
   PubMed     Text format     Abstract available
   
   
   May 2018
9. BIKBOV B, Perico N, Remuzzi G
   Disparities in Chronic Kidney Disease Prevalence among Males and Females in 195 Countries: Analysis of the Global Burden of Disease 2016 Study.
   Nephron. 2018 May 23:1-6. doi: 10.1159/000489897.
   PubMed     Text format     Abstract available
   
   
   April 2018
10. TRABULUS S, Oruc M, Ozgun E, Altiparmak MR, et al
    The Use of Low-Calcium Hemodialysis in the Treatment of Hypercalcemic Crisis.
    Nephron. 2018 Apr 19. pii: 000488502. doi: 10.1159/000488502.
    PubMed     Text format     Abstract available
    
    
    
11. LIM SY, Ko YS, Lee HY, Yang JH, et al
    The Impact of Preexisting Chronic Kidney Disease on the Severity and Recovery of Acute Kidney Injury.
    Nephron. 2018 Apr 12. pii: 000487492. doi: 10.1159/000487492.
    PubMed     Text format     Abstract available
    
    
    
12. LI CAVOLI G, Oliva B, Caputo F
    Dialysis Modality towards Kidney Transplant Outcomes.
    Nephron. 2018 Apr 3. pii: 000488503. doi: 10.1159/000488503.
    PubMed     Text format    
    
    
    March 2018
13. SAENGPANIT D, Chattranukulchai P, Tumkosit M, Siribumrungwong M, et al
    Effect of Sodium Thiosulfate on Arterial Stiffness in End-Stage Renal Disease Patients Undergoing Chronic Hemodialysis (Sodium Thiosulfate-Hemodialysis Study): A Randomized Controlled Trial.
    Nephron. 2018 Mar 23. pii: 000488009. doi: 10.1159/000488009.
    PubMed     Text format     Abstract available
    
    
    
14. MAJOR RW, Shepherd D, Brunskill NJ
    Reclassification of Chronic Kidney Disease Stage, Eligibility for Cystatin-C and Its Associated Costs in a UK Primary Care Cohort.
    Nephron. 2018;139:39-46.
    PubMed     Text format     Abstract available
    
    
    
15. TIRANATHANAGUL K, Susantitaphong P, Srisawat N, Mahatanan N, et al
    Ten-Year Survival of End-Stage Renal Disease Patients Treated with High-Efficiency Online Hemodiafiltration: A Cohort Study of a Center in South East Asia.
    Nephron. 2018 Mar 7. pii: 000487364. doi: 10.1159/000487364.
    PubMed     Text format     Abstract available
    
    
    
16. GREEVIROJ P, Kitrungphaiboon T, Katavetin P, Praditpornsilpa K, et al
    Cinacalcet for Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Nephron. 2018 Mar 7. pii: 000487546. doi: 10.1159/000487546.
    PubMed     Text format     Abstract available
    
    
    
17. NEZAMI N, Ghabili K, Shokouhi-Gogani B, Mirchi M, et al
    The Relationship between Carotid and Femoral Artery Intima-Media Thickness and Histopathologic Grade of Atherosclerosis in Patients with Chronic Kidney Disease.
    Nephron. 2018 Mar 7. pii: 000487491. doi: 10.1159/000487491.
    PubMed     Text format     Abstract available
    
    
    February 2018
18. LIU H, Lu R, Shastri S, Sonderman M, et al
    Assessing Extracellular Volume in Hemodialysis Patients Using Intradialytic Blood Pressure Slopes.
    Nephron. 2018 Feb 13. pii: 000487093. doi: 10.1159/000487093.
    PubMed     Text format     Abstract available
    
    
    
19. KOVAROVA L, Valerianova A, Kmentova T, Lachmanova J, et al
    Low Cerebral Oxygenation Is Associated with Cognitive Impairment in Chronic Hemodialysis Patients.
    Nephron. 2018 Feb 13. pii: 000487092. doi: 10.1159/000487092.
    PubMed     Text format     Abstract available
    
    
    
20. CALVINO J, Cigarran S, Gonzalez-Tabares L, Guijarro M, et al
    Restless Legs Syndrome: An Unresolved Uremic Disorder after Renal Transplantation.
    Nephron. 2018 Feb 1. pii: 000486401. doi: 10.1159/000486401.
    PubMed     Text format     Abstract available
    
    
    January 2018
21. ROZENBAUM Z, Benchetrit S, Rozenbaum E, Neumark E, et al
    Ultra-Low Contrast Volume for Patients with Advanced Chronic Kidney Disease Undergoing Coronary Procedures.
    Nephron. 2018 Jan 24. pii: 000485648. doi: 10.1159/000485648.
    PubMed     Text format     Abstract available
    
    
    
22. KIM TW, Chang TI, Kim TH, Chou JA, et al
    Association of Ultrafiltration Rate with Mortality in Incident Hemodialysis Patients.
    Nephron. 2018 Jan 18. pii: 000486323. doi: 10.1159/000486323.
    PubMed     Text format     Abstract available
    
    
    
23. HICKSON LJ, Thorsteinsdottir B, Ramar P, Reinalda MS, et al
    Hospital Readmission among New Dialysis Patients Associated with Young Age and Poor Functional Status.
    Nephron. 2018 Jan 9. pii: 000485985. doi: 10.1159/000485985.
    PubMed     Text format     Abstract available
    
    
    
24. WALLQUIST C, Mansouri L, Norrback M, Hylander B, et al
    Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease.
    Nephron. 2018 Jan 4. pii: 000485472. doi: 10.1159/000485472.
    PubMed     Text format     Abstract available
    
    
    
25. 
    Appendix E Methodology for Estimating Catchment Populations of Renal Centres in the UK for Dialysis.
    Nephron. 2018;139 Suppl 1:305-308.
    PubMed     Text format    
    
    
    
26. HOLE B, Magadi W, Steenkamp R, Fluck R, et al
    Chapter 10 Multisite Dialysis Access Audit in England, Northern Ireland and Wales and 2015 Peritoneal.
    Nephron. 2018;139 Suppl 1:253-272.
    PubMed     Text format    
    
    
    
27. PYART R, Casula A, Nicholas J, Dawnay A, et al
    Chapter 8 Biochemical Variables in UK Adult Dialysis Patients in 2016: National and Centre-specific.
    Nephron. 2018;139 Suppl 1:191-240.
    PubMed     Text format    
    
    
    
28. PYART R, Gilg J, Williams AJ
    Chapter 7 Haemoglobin, Ferritin and Erythropoietin in UK Adult Dialysis Patients in 2016: National and.
    Nephron. 2018;139 Suppl 1:165-190.
    PubMed     Text format    
    
    
    
29. PLUMB L, Casula A, Magadi W, Braddon F, et al
    Chapter 11 Clinical, Haematological and Biochemical Parameters in Patients on Renal Replacement Therapy.
    Nephron. 2018;139 Suppl 1:273-286.
    PubMed     Text format    
    
    
    
30. STEENKAMP R, Pyart R, Fraser S
    Chapter 5 Survival and Cause of Death in UK Adult Patients on Renal Replacement Therapy in 2016.
    Nephron. 2018;139 Suppl 1:117-150.
    PubMed     Text format    
    
    
    
31. PLUMB L, Wong E, Casula A, Braddon F, et al
    Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2016.
    Nephron. 2018;139 Suppl 1:105-116.
    PubMed     Text format    
    
    
    
32. MACNEILL SJ, Ford D, Evans K, Medcalf JF, et al
    Chapter 2 UK Renal Replacement Therapy Adult Prevalence in 2016: National and Centre-specific Analyses.
    Nephron. 2018;139 Suppl 1:47-74.
    PubMed     Text format    
    
    
    
33. HOLE B, Gilg J, Casula A, Methven S, et al
    Chapter 1 UK Renal Replacement Therapy Adult Incidence in 2016: National and Centre-specific Analyses.
    Nephron. 2018;139 Suppl 1:13-46.
    PubMed     Text format    
    
    
    December 2017
34. LEW QLJ, Allen JC, Nguyen F, Tan NC, et al
    Factors Associated with Chronic Kidney Disease and Their Clinical Utility in Primary Care Clinics in a Multi-Ethnic Southeast Asian Population.
    Nephron. 2017 Dec 15. pii: 000485110. doi: 10.1159/000485110.
    PubMed     Text format     Abstract available
    
    
    
35. MA TK, Chow KM, Kwan BC, Ng JK, et al
    Peritoneal Dialysis Catheter Revision and Replacement by Nephrologist for Peritoneal Dialysis Catheter Malfunction.
    Nephron. 2017 Dec 14. pii: 000485643. doi: 10.1159/000485643.
    PubMed     Text format     Abstract available
    
    
    
36. BAKKALOGLU SA, Ozdemir Atikel Y, Paglialonga F, Stefanidis CJ, et al
    Vaccination Practices in Pediatric Dialysis Patients Across Europe. A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group Study.
    Nephron. 2017 Dec 12. pii: 000485398. doi: 10.1159/000485398.
    PubMed     Text format     Abstract available
    
    
    November 2017
37. EL-HUSSEINI A, Wang K, Edon A, Saxon D, et al
    Value of Intraoperative Parathyroid Hormone Assay during Parathyroidectomy in Dialysis and Renal Transplant Patients with Secondary and Tertiary Hyperparathyroidism.
    Nephron. 2017 Nov 9. doi: 10.1159/000482016.
    PubMed     Text format     Abstract available
    
    
    
38. AKRAWI DS, PirouziFard M, Fjellstedt E, Sundquist J, et al
    Heritability of End-Stage Renal Disease: A Swedish Adoption Study.
    Nephron. 2017 Nov 9. doi: 10.1159/000484327.
    PubMed     Text format     Abstract available
    
    
    October 2017
39. POURAFSHAR N, Pourafshar S, Soleimani M
    Urine Ammonium, Metabolic Acidosis and Progression of Chronic Kidney Disease.
    Nephron. 2017 Oct 19. doi: 10.1159/000481892.
    PubMed     Text format     Abstract available
    
    
    September 2017
40. YANG CW
    Leptospirosis Renal Disease: Emerging Culprit of Chronic Kidney Disease Unknown Etiology.
    Nephron. 2017 Sep 20. doi: 10.1159/000480691.
    PubMed     Text format     Abstract available
    
    
    
41. VELOSO VSP, Ataides TL, Canziani MEF, Veloso MP, et al
    A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
    Nephron. 2017 Sep 12. doi: 10.1159/000479895.
    PubMed     Text format     Abstract available
    
    
    August 2017
42. WONG SPY, O'Hare AM
    Making Sense of Prognostic Information About Maintenance Dialysis versus Conservative Care for Treatment of Advanced Kidney Disease.
    Nephron. 2017 Aug 26. doi: 10.1159/000479804.
    PubMed     Text format    
    
    
    July 2017
43. RATHORE AS, Chopra T, Ma JZ, Xin W, et al
    Long-Term Outcomes and Associated Risk Factors of Post-Hospitalization Dialysis-Dependent Acute Kidney Injury Patients.
    Nephron. 2017;137:105-112.
    PubMed     Text format     Abstract available
    
    
    
44. TURGUT F, Abdel-Rahman EM
    Challenges Associated with Managing End-Stage Renal Disease in Extremely Morbid Obese Patients: Case Series and Literature Review.
    Nephron. 2017 Jul 28. doi: 10.1159/000479118.
    PubMed     Text format     Abstract available
    
    
    
45. JIALAL I, Camacho F, Nathoo B, Tam P, et al
    Fibroblast Growth Factor 23 Predicts Mortality and End-Stage Renal Disease in a Canadian Asian Population with Chronic Kidney Disease.
    Nephron. 2017 Jul 26. doi: 10.1159/000479300.
    PubMed     Text format     Abstract available
    
    
    
46. CARRARA C, Abbate M, Sabadini E, Remuzzi G, et al
    Acute Kidney Injury and Hemolytic Anemia Secondary to Mycoplasma pneumoniae Infection.
    Nephron. 2017 Jul 7. doi: 10.1159/000478991.
    PubMed     Text format     Abstract available
    
    
    June 2017
47. NG HY, Hsueh SK, Lee YT, Chiou TT, et al
    Synergic Impact of Vascular Calcification and Low Autonomic Tone in Mortality of Hemodialysis Patients.
    Nephron. 2017 Jun 22. doi: 10.1159/000477827.
    PubMed     Text format     Abstract available
    
    
    
48. HUKRIEDE N, Vogt A, de Caestecker M
    Drug Discovery to Halt the Progression of Acute Kidney Injury to Chronic Kidney Disease: A Case for Phenotypic Drug Discovery in Acute Kidney Injury.
    Nephron. 2017 Jun 15. doi: 10.1159/000476079.
    PubMed     Text format     Abstract available
    
    
    
49. FILHO AMS, Ventura CG, Criado PR, Del Negro GB, et al
    Hemodialysis and Kidney Transplantation as Predisposing Conditions to Onychomycosis.
    Nephron. 2017 Jun 14. doi: 10.1159/000475674.
    PubMed     Text format     Abstract available
    
    
    
50. O HAINMHIRE E, Humphreys BD
    Fibrotic Changes Mediating Acute Kidney Injury to Chronic Kidney Disease Transition.
    Nephron. 2017 Jun 9. doi: 10.1159/000474960.
    PubMed     Text format     Abstract available
    
    
    
51. NANGAKU M, Hirakawa Y, Mimura I, Inagi R, et al
    Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nephron. 2017 Jun 9. doi: 10.1159/000476078.
    PubMed     Text format     Abstract available
    
    
    
52. SEKKARIE MA, Abdel-Rahman EM
    Cultural Challenges in the Care of Refugees with End-Stage Renal Disease: What Western Nephrologists Should Know.
    Nephron. 2017 Jun 8. doi: 10.1159/000477362.
    PubMed     Text format     Abstract available
    
    
    
53. BROERS NJH, Martens RJH, Cornelis T, van der Sande FM, et al
    Physical Activity in End-Stage Renal Disease Patients: The Effects of Starting Dialysis in the First 6 Months after the Transition Period.
    Nephron. 2017 Jun 8. doi: 10.1159/000476072.
    PubMed     Text format     Abstract available
    
    
    May 2017
54. WONGRAKPANICH S, Susantitaphong P, Isaranuwatchai S, Chenbhanich J, et al
    Dialysis Therapy and Conservative Management of Advanced Chronic Kidney Disease in the Elderly: A Systematic Review.
    Nephron. 2017 May 25. doi: 10.1159/000477361.
    PubMed     Text format     Abstract available
    
    
    
55. SALEH T, Sumida K, Molnar MZ, Potukuchi PK, et al
    Effect of Age on the Association of Vascular Access Type with Mortality in a Cohort of Incident End-Stage Renal Disease Patients.
    Nephron. 2017 May 18. doi: 10.1159/000477271.
    PubMed     Text format     Abstract available
    
    
    
56. BRITO JS, Borges NA, Esgalhado M, Magliano DC, et al
    Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Nephron. 2017 May 11. doi: 10.1159/000476074.
    PubMed     Text format     Abstract available
    
    
    
57. GRANDJEAN-THOMSEN NL, Marley P, Shadbolt B, Farshid A, et al
    Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Nephron. 2017 May 6. doi: 10.1159/000473863.
    PubMed     Text format     Abstract available
    
    
    
58. ALFANO G, Fontana F, Cappelli G
    Noninvasive Blood Pressure Measurement in Maintenance Hemodialysis Patients: Comparison of Agreement between Oscillometric and Finger-Cuff Methods.
    Nephron. 2017 May 4. doi: 10.1159/000457812.
    PubMed     Text format     Abstract available
    
    
    April 2017
59. ARIF FM, Sumida K, Molnar MZ, Potukuchi PK, et al
    Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease.
    Nephron. 2017 Apr 27. doi: 10.1159/000473704.
    PubMed     Text format     Abstract available
    
    
    
60. BORJI R, Ahmadi SH, Barkhordari K, Meysami AP, et al
    Effect of Prophylactic Dialysis on Morbidity and Mortality in Non-Dialysis-Dependent Patients after Coronary Artery Bypass Grafting: A Pilot Study.
    Nephron. 2017;136.
    PubMed     Text format     Abstract available
    
    
    
61. MUDI A, Ntsinjana H, Dickens C, Levy C, et al
    Cardiac Changes and Their Association with Fetuin-A and Fibroblast Growth Factor-23 in Children with Chronic Kidney Disease.
    Nephron. 2017 Apr 13. doi: 10.1159/000470858.
    PubMed     Text format     Abstract available
    
    
    
62. MANSOURI L, Nopp A, Jacobson SH, Hylander B, et al
    Hemodialysis Patients Display a Declined Proportion of Th2 and Regulatory T Cells in Parallel with a High Interferon-gamma Profile.
    Nephron. 2017 Apr 6. doi: 10.1159/000471814.
    PubMed     Text format     Abstract available
    
    
    March 2017
63. YAP N, Wong P, McGinn S, Nery ML, et al
    Femoral Neck X-Ray Absorptiometry Parameters and Peripheral Quantitative Computer Tomography Tibial Cortical Density Predict Survival in Dialysis Patients.
    Nephron. 2017 Mar 21. doi: 10.1159/000460262.
    PubMed     Text format     Abstract available
    
    
    
64. OMOTOSO BA, Turgut F, Abdel-Rahman EM, Xin W, et al
    Dialysis Requirement and Long-Term Major Adverse Cardiovascular Events in Patients with Chronic Kidney Disease and Superimposed Acute Kidney Injury.
    Nephron. 2017 Mar 2. doi: 10.1159/000455749.
    PubMed     Text format     Abstract available
    
    
    
65. NGUYEN HA, Anderson CA, Miracle CM, Rifkin DE, et al
    The Association between Depression, Perceived Health Status, and Quality of Life among Individuals with Chronic Kidney Disease: An Analysis of the National Health and Nutrition Examination Survey 2011-2012.
    Nephron. 2017 Mar 2. doi: 10.1159/000455750.
    PubMed     Text format     Abstract available
    
    
    February 2017
66. PEREZ FONTAN M, Borras Sans M, Bajo Rubio MA, Rodriguez-Carmona A, et al
    Low Serum Levels of Vitamin D are Associated with Progression of Subclinical Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients: A Prospective, Multicenter Study.
    Nephron. 2017 Feb 25. doi: 10.1159/000458418.
    PubMed     Text format     Abstract available
    
    
    
67. YOUSSOUF S, Nache A, Wijesekara C, Middleton RJ, et al
    Effect of a Quality Improvement Program to Improve Guideline Adherence and Attainment of Clinical Standards in Dialysis Care: Report of Outcomes in Year 1.
    Nephron. 2017 Feb 25. doi: 10.1159/000450890.
    PubMed     Text format     Abstract available
    
    
    
68. HOCHER B, Yin L
    Current Parathyroid Hormone Assays May Mislead Clinical Decision Making Particularly in Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
    Nephron. 2017 Feb 10. doi: 10.1159/000455289.
    PubMed     Text format     Abstract available
    
    
    
69. MOMOSE A, Shiraiwa Y, Narita S, Kusumi T, et al
    Total Calcium and Albumin Are Decreased in the Deeper Epidermis of Patients with Chronic Kidney Disease-Associated Pruritus.
    Nephron. 2017 Feb 10. doi: 10.1159/000458417.
    PubMed     Text format     Abstract available
    
    
    
70. WALKER SR, Komenda P, Khojah S, Al-Tuwaijri W, et al
    Dipeptidyl Peptidase-4 Inhibitors in Chronic Kidney Disease: A Systematic Review of Randomized Clinical Trials.
    Nephron. 2017 Feb 9. doi: 10.1159/000454683.
    PubMed     Text format     Abstract available
    
    
    
71. TYSON CC, Coffman TM
    In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
    Nephron. 2017;135:287-290.
    PubMed     Text format     Abstract available
    
    
    
72. GHOUTI-TERKI L, Chasseuil E, Rabot N, Paintaud G, et al
    Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Nephron. 2017 Feb 3. doi: 10.1159/000453005.
    PubMed     Text format     Abstract available
    
    
    January 2017
73. GREEN D, Skeoch S, Alexander MY, Kalra PA, et al
    The Association of Baseline and Longitudinal Change in Endothelial Microparticle Count with Mortality in Chronic Kidney Disease.
    Nephron. 2017 Jan 25. doi: 10.1159/000452344.
    PubMed     Text format     Abstract available
    
    
    
74. MOMOKI K, Yamaguchi T, Ohashi K, Ando M, et al
    Emergence of Dipstick Proteinuria Predicts Overt Nephropathy in Patients Following Stem Cell Transplantation.
    Nephron. 2017;135:31-38.
    PubMed     Text format     Abstract available
    
    
    
75. 
    UK Renal Registry 19th Annual Report: Appendix E Methodology for Estimating Catchment Populations of Renal Centres in the UK for Dialysis Patients.
    Nephron. 2017;137 Suppl 1:347-350.
    PubMed     Text format    
    
    
    
76. HOLE B, Caskey F, Evans K, Fluck R, et al
    UK Renal Registry 19th Annual Report: Chapter 12 Multisite Dialysis Access Audit in England, Northern Ireland and Wales in 2015 and 2014 PD One Year Follow-up: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:269-296.
    PubMed     Text format    
    
    
    
77. CROWLEY L, MacNeill S, Methven S, Nsonwu O, et al
    UK Renal Registry 19th Annual Report: Chapter 10 Epidemiology of Reported Infections in Patients Receiving Dialysis in England between January 2015 and December 2015: a Joint Report from Public Health England and the UK Renal Registry.
    Nephron. 2017;137 Suppl 1:251-258.
    PubMed     Text format    
    
    
    
78. METHVEN S, Perisanidou LI, Nicholas J, Dawnay A, et al
    UK Renal Registry 19th Annual Report: Chapter 8 Biochemical Variables amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:189-234.
    PubMed     Text format    
    
    
    
79. FORD D, Gilg J, Williams AJ
    UK Renal Registry 19th Annual Report: Chapter 7 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:165-188.
    PubMed     Text format    
    
    
    
80. HAMILTON AJ, Braddon F, Casula A, Lewis M, et al
    UK Renal Registry 19th Annual Report: Chapter 9 Clinical, Haematological and Biochemical Parameters in Patients on Renal Replacement Therapy in Paediatric Centres in the UK in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:235-250.
    PubMed     Text format    
    
    
    
81. METHVEN S, Steenkamp R, Fraser S
    UK Renal Registry 19th Annual Report: Chapter 5 Survival and Causes of Death in UK Adult Patients on Renal Replacement Therapy in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:117-150.
    PubMed     Text format    
    
    
    
82. HAMILTON AJ, Braddon F, Casula A, Lewis M, et al
    UK Renal Registry 19th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2015.
    Nephron. 2017;137 Suppl 1:103-116.
    PubMed     Text format    
    
    
    
83. MACNEILL SJ, Ford D
    UK Renal Registry 19th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:45-72.
    PubMed     Text format    
    
    
    December 2016
84. SEIBERT E, Muller SG, Pattmoller J, Kotanko P, et al
    Calf Resistivity Values in Chronic Kidney Disease in a Caucasian Population.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
85. YAMAGUCHI J, Tanaka T, Inagi R
    Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
86. THAMRATNOPKOON S, Susantitaphong P, Tumkosit M, Katavetin P, et al
    Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
87. CORTINOVIS M, Gotti E, Trillini M, Carrara F, et al
    Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
88. MUENDLEIN A, Ebner J, Zitt E
    Prevalence of the Janus Kinase 2 V617F Mutation in Patients with End-Stage Renal Disease.
    Nephron. 2016.
    PubMed     Text format    
    
    
    
89. WU B, Jiang H, He Q, Wang M, et al
    Liquid Chromatography/Mass Spectrometry Reveals the Effect of Lactobacillus Treatment on the Faecal Metabolite Profile of Rats with Chronic Renal Failure.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
90. SANCHEZ V, Paniagua R, Prado MD, Mora C, et al
    High Prevalence of Diastolic Dysfunction in Incident Patients on Peritoneal Dialysis: Association with Low Thyroid Hormones.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
91. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Martin-Cleary C, Pizarro-Sanchez MS, et al
    Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
92. BORONAT M, Santana A, Bosch E, Lorenzo D, et al
    Relationship between Anemia and Serum Concentrations of Calcium and Phosphorus in Advanced Non-Dialysis-Dependent Chronic Kidney Disease.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
93. RHEE CM, Kovesdy CP, Kalantar-Zadeh K
    Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
94. KIKUCHI M, Ueno M, Itoh Y, Suda W, et al
    Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
95. SILVA CA, Barreto FC, Dos Reis MA, Moura Junior JA, et al
    Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
    Nephron. 2016;134:221-230.
    PubMed     Text format     Abstract available
    
    
    July 2016
96. ADEMA AY, de Jong MA, de Borst MH, Ter Wee PM, et al
    Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT).
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
97. YAMASAKI A, Yoda K, Koyama H, Yamada S, et al
    Association of Erythropoietin Resistance with Fatigue in Hemodialysis Patients: A Cross-Sectional Study.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
98. TAKAORI K, Yanagita M
    Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.
    Nephron. 2016.
    PubMed     Text format     Abstract available
    
    
    
99. BOVIO G, Esposito C, Montagna G, Brazzo S, et al
    Inadequate Macronutrient and Micronutrient Intakes in Hemodialysis and Peritoneal Dialysis Patients: Data from a Seven-Day Weighed Dietary Record.
    Nephron. 2016;133.
    PubMed     Text format     Abstract available
    
    
    
100. RENNIE TJ, Patton A, Dreischulte T, Bell S, et al
     Incidence and Outcomes of Acute Kidney Injury Requiring Renal Replacement Therapy: A Retrospective Cohort Study.
     Nephron. 2016.
     PubMed     Text format     Abstract available
     
     
     
101. GURU PK, Singh TD, Akhoundi A, Kashani KB, et al
     Association of Thrombocytopenia and Mortality in Critically Ill Patients on Continuous Renal Replacement Therapy.
     Nephron. 2016;133:175-182.
     PubMed     Text format     Abstract available
     
     
     
102. GILLIS KA, McComb C, Patel RK, Stevens KK, et al
     Non-Contrast Renal Magnetic Resonance Imaging to Assess Perfusion and Corticomedullary Differentiation in Health and Chronic Kidney Disease.
     Nephron. 2016.
     PubMed     Text format     Abstract available
     
     
     June 2016
103. MALIK J, Lachmanova J, Kudlicka J, Rocinova K, et al
     Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis.
     Nephron. 2016.
     PubMed     Text format     Abstract available
     
     
     
104. DE VRIES EF, Rabelink TJ, van den Hout WB
     Modelling the Cost-Effectiveness of Delaying End-Stage Renal Disease.
     Nephron. 2016.
     PubMed     Text format     Abstract available
     
     
     April 2016
105. MAJOR R, Shepherd D, Warwick G, Brunskill N, et al
     Prescription Rates of Cardiovascular Medications in a Large UK Primary Care Chronic Kidney Disease Cohort.
     Nephron. 2016.
     PubMed     Text format     Abstract available
     
     
     January 2016
106. LINES SW, Richardson VR, Thomas B, Dunn EJ, et al
     Complement and Cardiovascular Disease--The Missing Link in Haemodialysis Patients.
     Nephron. 2016;132:5-14.
     PubMed     Text format     Abstract available
     
     
     
107. FEEHALLY J, Coppo R, Troyanov S, Bellur SS, et al
     Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.
     Nephron. 2016;132:15-24.
     PubMed     Text format     Abstract available
     
     
     
108. BAGCHI S, Agarwal S, Kalaivani M, Bhowmik D, et al
     Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
     Nephron. 2016;132:81-5.
     PubMed     Text format     Abstract available
     
     
     
109. PRUTHI R, Casula A, MacPhee I
     UK Renal Registry 18th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2014: National and Centre-specific Analyses.
     Nephron. 2016;132 Suppl 1:69-98.
     PubMed     Text format     Abstract available
     
     
     
110. DAVENPORT A, Shaw C, Steenkamp R
     UK Renal Registry 18th Annual Report: Chapter 7 Adequacy of Haemodialysis in UK Adult Patients in 2014: National and Centre-specific Analyses.
     Nephron. 2016;132 Suppl 1:155-68.
     PubMed     Text format     Abstract available
     
     
     
111. AHMED A, Jorna T, Bhandari S
     Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
     Nephron. 2016;133:147-58.
     PubMed     Text format     Abstract available
     
     
     
112. MADUELL F, Ojeda R, Arias-Guillen M, Rossi F, et al
     Eight-Year Experience with Nocturnal, Every-Other-Day, Online Haemodiafiltration.
     Nephron. 2016;133:98-110.
     PubMed     Text format     Abstract available
     
     
     
113. WARNOCK DG
     Estimated Glomerular Filtration Rate: Fit for What Purpose?
     Nephron. 2016;134:43-9.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: